Manufacturing for Good
Alex discusses the unexpected success of their direct-to-consumer model, which emerged to provide affordable access to essential medications. By focusing on manufacturing drugs that are often neglected due to low demand, they aim to address critical shortages, particularly in pediatric oncology, where thousands of children suffer from a lack of necessary treatments. Their approach emphasizes using vertical integration to tackle healthcare disparities rather than simply capitalizing on existing markets.In this clip
From this podcast
Masters of Scale
Rapid Response: How Cost Plus Drugs is revolutionizing pharma, with CEO Alex Oshmyansky
Related Questions